Federal Circuit Rejects Tribal Sovereign Immunity Defense in IPR Proceedings

The appeal stemmed from a dispute between Allergan, Inc. and Mylan Pharmaceuticals, Inc. regarding several patents relating to Allergan’s Restasis …